Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 671417, 10 pages
http://dx.doi.org/10.1155/2015/671417
Review Article

Macrophages and Uveitis in Experimental Animal Models

1Instituto de Ciencias Biomédicas, Universidad CEU Cardenal Herrera, 46113 Valencia, Spain
2FISABIO, Oftalmología Médica, 46020 Valencia, Spain

Received 16 January 2015; Revised 14 March 2015; Accepted 31 March 2015

Academic Editor: Analía Trevani

Copyright © 2015 Salvador Mérida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Y. Lowder and D. H. Char, “Uveitis. A review,” Western Journal of Medicine, vol. 140, no. 3, pp. 421–432, 1984. View at Google Scholar · View at Scopus
  2. E. Bloch-Michel and R. B. Nussenblatt, “International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease,” American Journal of Ophthalmology, vol. 103, no. 2, pp. 234–235, 1987. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Jabs, R. B. Nussenblatt, and J. T. Rosenbaum, “Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop,” American Journal of Ophthalmology, vol. 140, no. 3, pp. 509–516, 2005. View at Publisher · View at Google Scholar
  4. J. Deschenes, P. I. Murray, N. A. Rao, and R. B. Nussenblatt, “International Uveitis Study Group (IUSG): clinical classification of uveitis,” Ocular Immunology and Inflammation, vol. 16, no. 1-2, pp. 1–2, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. S. London, S. R. Rathinam, and E. T. Cunningham Jr., “The epidemiology of uveitis in developing countries,” International Ophthalmology Clinics, vol. 50, no. 2, pp. 1–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Päivönsalo-Hietanen, J. Tuominen, H. Vaahtoranta-Lehtonen, and K. M. Saari, “Incidence and prevalence of different uveitis entities in Finland,” Acta Ophthalmologica Scandinavica, vol. 75, no. 1, pp. 76–81, 1997. View at Google Scholar · View at Scopus
  7. D. C. Gritz and I. G. Wong, “Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study,” Ophthalmology, vol. 111, no. 3, pp. 491–500, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Rathinam, R. Krishnadas, R. Ramakrishnan et al., “Population-based prevalence of uveitis in Southern India,” British Journal of Ophthalmology, vol. 95, no. 4, pp. 463–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D.-K. Hwang, Y.-J. Chou, C.-Y. Pu, and P. Chou, “Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study,” Ophthalmology, vol. 119, no. 11, pp. 2371–2376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Tomkins-Netzer, L. Talat, A. Bar et al., “Long-term clinical outcome and causes of vision loss in patients with uveitis,” Ophthalmology, vol. 121, no. 12, pp. 2387–2392, 2014. View at Publisher · View at Google Scholar
  11. O. M. Durrani, N. N. Tehrani, J. E. Marr, P. Moradi, P. Stavrou, and P. I. Murray, “Degree, duration, and causes of visual loss in uveitis,” British Journal of Ophthalmology, vol. 88, no. 9, pp. 1159–1162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. R. van Furth, Z. A. Cohn, J. G. Hirsch, J. H. Humphrey, W. G. Spector, and H. L. Langevoort, “The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells,” Bulletin of the World Health Organization, vol. 46, no. 6, pp. 845–852, 1972. View at Google Scholar · View at Scopus
  13. C. Zhang and M. O. M. Tso, “Characterization of activated retinal microglia following optic axotomy,” Journal of Neuroscience Research, vol. 73, no. 6, pp. 840–845, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. D. Dick, “Influence of microglia on retinal progenitor cell turnover and cell replacement,” Eye, vol. 23, no. 10, pp. 1939–1945, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kettenmann, U.-K. Hanisch, M. Noda, and A. Verkhratsky, “Physiology of microglia,” Physiological Reviews, vol. 91, no. 2, pp. 461–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Xu, M. Chen, E. J. Mayer, J. V. Forrester, and A. D. Dick, “Turnover of resident retinal microglia in the normal adult mouse,” Glia, vol. 55, no. 11, pp. 1189–1198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Karlstetter, S. Ebert, and T. Langmann, “Microglia in the healthy and degenerating retina: insights from novel mouse models,” Immunobiology, vol. 215, no. 9-10, pp. 685–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Geissmann, M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley, “Development of monocytes, macrophages, and dendritic cells,” Science, vol. 327, no. 5966, pp. 656–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Kezic and P. G. McMenamin, “Differential turnover rates of monocyte-derived cells in varied ocular tissue microenvironments,” Journal of Leukocyte Biology, vol. 84, no. 3, pp. 721–729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kaneko, K. M. Nishiguchi, M. Nakamura, S. Kachi, and H. Terasaki, “Characteristics of bone marrow-derived microglia in the normal and injured retina,” Investigative Ophthalmology & Visual Science, vol. 49, no. 9, pp. 4162–4168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. G. McMenamin, J. Crewe, S. Morrison, and P. G. Holt, “Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye,” Investigative Ophthalmology & Visual Science, vol. 35, no. 8, pp. 3234–3250, 1994. View at Google Scholar · View at Scopus
  22. P. G. McMenamin, “Dendritic cells and macrophages in the uveal tract of the normal mouse eye,” British Journal of Ophthalmology, vol. 83, no. 5, pp. 598–604, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. J. E. Knickelbein, K.-A. Buela, and R. L. Hendricks, “Antigen-presenting cells are stratified within normal human corneas and are rapidly mobilized during ex vivo viral infection,” Investigative Ophthalmology & Visual Science, vol. 55, no. 2, pp. 1118–1123, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Knop and N. Knop, “Anatomy and immunology of the ocular surface,” Chemical Immunology and Allergy, vol. 92, pp. 36–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Yamagami, S. Yokoo, T. Usui, H. Yamagami, S. Amano, and N. Ebihara, “Distinct populations of dendritic cells in the normal human donor corneal epithelium,” Investigative Ophthalmology & Visual Science, vol. 46, no. 12, pp. 4489–4494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Yamagami, N. Ebihara, T. Usui, S. Yokoo, and S. Amano, “Bone marrow-derived cells in normal human corneal stroma,” Archives of Ophthalmology, vol. 124, no. 1, pp. 62–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Yamagami, S. Yokoo, S. Amano, and N. Ebihara, “Characterization of bone marrow-derived cells in the substantia propria of the human conjunctiva,” Investigative Ophthalmology & Visual Science, vol. 48, no. 10, pp. 4476–4481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. F. Cesta, “Normal structure, function, and histology of mucosa-associated lymphoid tissue,” Toxicologic Pathology, vol. 34, no. 5, pp. 599–608, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Agnifili, R. Mastropasqua, V. Fasanella et al., “In vivo confocal microscopy of conjunctiva-associated lymphoid tissue in healthy humans,” Investigative Ophthalmology & Visual Science, vol. 55, no. 8, pp. 5254–5262, 2014. View at Google Scholar
  30. M. J. Ali, K. Mulay, A. Pujari, and M. N. Naik, “Derangements of lacrimal drainage-associated lymphoid tissue (LDALT) in human chronic dacryocystitis,” Ocular Immunology & Inflammation, vol. 21, no. 6, pp. 417–423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. R. Santiago, F. I. Baptista, P. F. Santos et al., “Role of microglia adenosine A2A receptors in retinal and brain neurodegenerative diseases,” Mediators of Inflammation, vol. 2014, Article ID 465694, 13 pages, 2014. View at Publisher · View at Google Scholar
  32. D. A. Hume, V. H. Perry, and S. Gordon, “Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation in microglial cells to form a regular array in the plexiform layers,” Journal of Cell Biology, vol. 97, no. 1, pp. 253–257, 1983. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Huang, J. Cui, L. Li, P. F. Hitchcock, and Y. Li, “The role of microglia in the neurogenesis of zebrafish retina,” Biochemical and Biophysical Research Communications, vol. 421, no. 2, pp. 214–220, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Checchin, F. Sennlaub, E. Levavasseur, M. Leduc, and S. Chemtob, “Potential role of microglia in retinal blood vessel formation,” Investigative Ophthalmology and Visual Science, vol. 47, no. 8, pp. 3595–3602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology, vol. 8, no. 12, pp. 958–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. K. Biswas and A. Mantovani, “Orchestration of metabolism by macrophages,” Cell Metabolism, vol. 15, no. 4, pp. 432–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Murray, J. Allen, S. Biswas et al., “Macrophage activation and polarization: nomenclature and experimental guidelines,” Immunity, vol. 41, no. 1, pp. 14–20, 2014. View at Publisher · View at Google Scholar
  38. J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, no. 1, pp. 767–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. A. K. Denniston, P. Tomlins, G. P. Williams et al., “Aqueous humor suppression of dendritic cell function helps maintain immune regulation in the eye during human uveitis,” Investigative Ophthalmology & Visual Science, vol. 53, no. 2, pp. 888–896, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Y. Niederkorn, “See no evil, hear no evil, do no evil: the lessons of immune privilege,” Nature Immunology, vol. 7, no. 4, pp. 354–359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. W. Taylor, “Ocular immune privilege,” Eye, vol. 23, no. 10, pp. 1885–1889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. V. Forrester and H. Xu, “Good news-bad news: the Yin and Yang of immune privilege in the eye,” Frontiers in Immunology, vol. 3, article 338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. W. Streilein, “Regulation of ocular immune responses,” Eye, vol. 11, no. 2, pp. 171–175, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Shechter, A. London, and M. Schwartz, “Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates,” Nature Reviews Immunology, vol. 13, no. 3, pp. 206–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. G. A. Wilbanks and J. W. Streilein, “Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes,” Immunology, vol. 71, no. 4, pp. 566–572, 1990. View at Google Scholar · View at Scopus
  46. J. W. Streilein, “Ocular immune privilege: therapeutic opportunities from an experiment of nature,” Nature Reviews Immunology, vol. 3, no. 11, pp. 879–889, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Stein-Streilein and A. W. Taylor, “An eye's view of T regulatory cells,” Journal of Leukocyte Biology, vol. 81, no. 3, pp. 593–598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. H. M. Ashour and J. Y. Niederkorn, “Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation,” Journal of Immunology, vol. 176, no. 10, pp. 5950–5957, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Gu, A. Y. Chhabra, P. Alard, D. R. Warner, and M. M. Kosiewicz, “FcγRI is required for TGFβ2-treated macrophage-induced tolerance,” Immunobiology, vol. 218, no. 9, pp. 1200–1206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. V. Forrester, H. Xu, L. Kuffová, A. D. Dick, and P. G. McMenamin, “Dendritic cell physiology and function in the eye,” Immunological Reviews, vol. 234, no. 1, pp. 282–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. R. Caspi, “Understanding autoimmune uveitis through animal models: the friedenwald lecture,” Investigative Ophthalmology & Visual Science, vol. 52, no. 3, pp. 1873–1879, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. S. M. Hsu, R. Mathew, A. W. Taylor, and J. Stein-Streilein, “Ex-vivo tolerogenic F4/80+ antigen-presenting cells (APC) induce efferent CD8+ regulatory T cell-dependent suppression of experimental autoimmune uveitis,” Clinical & Experimental Immunology, vol. 176, no. 1, pp. 37–48, 2014. View at Publisher · View at Google Scholar
  53. J. H. Chang, P. J. McCluskey, and D. Wakefield, “Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease,” British Journal of Ophthalmology, vol. 90, no. 1, pp. 103–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Kerrigan and G. D. Brown, “C-type lectins and phagocytosis,” Immunobiology, vol. 214, no. 7, pp. 562–575, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Rajendram, S. Saraswathy, and N. A. Rao, “Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis,” British Journal of Ophthalmology, vol. 91, no. 4, pp. 531–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Bosch-Morell, J. Romá, N. Marín et al., “Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen,” Free Radical Biology and Medicine, vol. 33, no. 5, pp. 669–675, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. H. J. Forman and M. Torres, “Redox signaling in macrophages,” Molecular Aspects of Medicine, vol. 22, no. 4-5, pp. 189–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. G.-S. Wu, A. Sevanian, and N. A. Rao, “Detection of retinal lipid hydroperoxides in experimental uveitis,” Free Radical Biology and Medicine, vol. 12, no. 1, pp. 19–27, 1992. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Bosch-Morell, A. Sanz, M. Díaz-Llopis, and F. J. Romero, “Lipid peroxidation products in human subretinal fluid,” Free Radical Biology and Medicine, vol. 20, no. 7, pp. 899–903, 1996. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Gordon, “The macrophage: past, present and future,” European Journal of Immunology, vol. 37, no. 1, pp. S9–S17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology, vol. 27, pp. 229–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Martinon, “Signaling by ROS drives inflammasome activation,” European Journal of Immunology, vol. 40, no. 3, pp. 616–619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. M. Steinman, “Dendritic cells: understanding immunogenicity,” European Journal of Immunology, vol. 37, supplement 1, pp. S53–S60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Y. Slaney, A. Toker, A. L. Flamme, B. T. Bäckström, and J. L. Harper, “Naïve blood monocytes suppress T-cell function. A possible mechanism for protection from autoimmunity,” Immunology and Cell Biology, vol. 89, no. 1, pp. 7–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. B. Zhu, J. K. Kennedy, Y. Wang et al., “Plasticity of Ly-6Chi myeloid cells in T cell regulation,” The Journal of Immunology, vol. 187, no. 5, pp. 2418–2432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. G. B. Mackaness, “Cellular resistance to infection,” The Journal of Experimental Medicine, vol. 116, pp. 381–406, 1962. View at Publisher · View at Google Scholar · View at Scopus
  67. C. F. Nathan, H. W. Murray, M. E. Wiebe, and B. Y. Rubin, “Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity,” The Journal of Experimental Medicine, vol. 158, no. 3, pp. 670–689, 1983. View at Publisher · View at Google Scholar · View at Scopus
  68. J. L. Pace, S. W. Russell, R. D. Schreiber, A. Altman, and D. H. Katz, “Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-γ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 12 I, pp. 3782–3786, 1983. View at Publisher · View at Google Scholar · View at Scopus
  69. D. K. Dalton, S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart, “Multiple defects of immune cell function in mice with disrupted interferon-gamma genes,” Science, vol. 259, no. 5102, pp. 1739–1742, 1993. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati, “The chemokine system in diverse forms of macrophage activation and polarization,” Trends in Immunology, vol. 25, no. 12, pp. 677–686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Pesce, M. Kaviratne, T. R. Ramalingam et al., “The IL-21 receptor augments Th2 effector function and alternative macrophage activation,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 2044–2055, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. L. D. Hazlett, S. A. McClellan, R. P. Barrett et al., “IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis,” Investigative Ophthalmology & Visual Science, vol. 51, no. 3, pp. 1524–1532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. R. R. Caspi, F. G. Roberge, C.-C. Chan et al., “A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens,” The Journal of Immunology, vol. 140, no. 5, pp. 1490–1495, 1988. View at Google Scholar · View at Scopus
  74. R. K. Agarwal, P. B. Silver, and R. R. Caspi, “Rodent models of experimental autoimmune uveitis,” in Autoimmunity, pp. 443–469, Humana Press, 2012. View at Google Scholar
  75. M. J. Mattapallil, P. B. Silver, J. J. Mattapallil et al., “Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells,” The Journal of Immunology, vol. 187, no. 4, pp. 1977–1985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. G. Pennesi, M. J. Mattapallil, S.-H. Sun et al., “A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice,” Journal of Clinical Investigation, vol. 111, no. 8, pp. 1171–1180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Horai, P. B. Silver, J. Chen et al., “Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen,” Journal of Autoimmunity, vol. 44, pp. 21–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. J. DeVoss, Y. Hou, K. Johannes et al., “Spontaneous autoimmunity prevented by thymic expression of a single self-antigen,” The Journal of Experimental Medicine, vol. 203, no. 12, pp. 2727–2735, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. de Kozak, S. Camelo, and M. Pla, “Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: relevance to human pathologies,” Ophthalmic Research, vol. 40, no. 3-4, pp. 175–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Lambe, J. C. H. Leung, H. Ferry et al., “Limited peripheral T cell anergy predisposes to retinal autoimmunity,” The Journal of Immunology, vol. 178, no. 7, pp. 4276–4283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. J. V. Forrester, J. Liversidge, H. S. Dua, H. Towler, and P. G. McMenamin, “Comparison of clinical and experimental uveitis,” Current Eye Research, vol. 9, supplement 1, pp. 75–84, 1990. View at Publisher · View at Google Scholar · View at Scopus
  82. J. V. Forrester, I. Huitinga, L. Lumsden, and C. D. Dijkstra, “Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats,” Current Eye Research, vol. 17, no. 4, pp. 426–437, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. H.-R. Jiang, L. Lumsden, and J. V. Forrester, “Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice,” Investigative Ophthalmology & Visual Science, vol. 40, no. 13, pp. 3177–3185, 1999. View at Google Scholar · View at Scopus
  84. M. J. Robertson, L. P. Erwig, J. Liversidge, J. V. Forrester, A. J. Rees, and A. D. Dick, “Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis,” Investigative Ophthalmology & Visual Science, vol. 43, no. 7, pp. 2250–2257, 2002. View at Google Scholar · View at Scopus
  85. T. K. Khera, D. A. Copland, J. Boldison et al., “Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitis,” Clinical & Experimental Immunology, vol. 168, no. 2, pp. 165–177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Liversidge, A. Dick, and S. Gordon, “Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis,” The American Journal of Pathology, vol. 160, no. 3, pp. 905–916, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. C. J. Calder, L. B. Nicholson, and A. D. Dick, “A selective role for the TNF p55 receptor in autocrine signaling following IFN-γ stimulation in experimental autoimmune uveoretinitis,” Journal of Immunology, vol. 175, no. 10, pp. 6286–6293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. B. J. E. Raveney, D. A. Copland, C. J. Calder, A. D. Dick, and L. B. Nicholson, “TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation,” Immunology, vol. 131, no. 3, pp. 340–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. A. London, I. Benhar, M. J. Mattapallil, M. Mack, R. R. Caspi, and M. Schwartz, “Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology,” The Journal of Immunology, vol. 190, no. 7, pp. 3570–3578, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. P. C. Rodriguez, C. P. Hernandez, D. Quiceno et al., “Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma,” The Journal of Experimental Medicine, vol. 202, no. 7, pp. 931–939, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. H. Harizi, C. Grosset, and N. Gualde, “Prostaglandin E2 modulates dendritic cell function via EP 2 and EP4 receptor subtypes,” Journal of Leukocyte Biology, vol. 73, no. 6, pp. 756–763, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. L. Denney, W. L. Kok, S. L. Cole, S. Sanderson, A. J. McMichael, and L.-P. Ho, “Activation of invariant NKT cells in early phase of experimental autoimmune encephalomyelitis results in differentiation of Ly6Chi inflammatory monocyte to M2 macrophages and improved outcome,” The Journal of Immunology, vol. 189, no. 2, pp. 551–557, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. L. V. Rizzo, H. Xu, C.-C. Chan, B. Wiggert, and R. R. Caspi, “IL-10 has a protective role in experimental autoimmune uveoretinitis,” International Immunology, vol. 10, no. 6, pp. 807–814, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. O. Akbari, R. H. DeKruyff, and D. T. Umetsu, “Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen,” Nature Immunology, vol. 2, no. 8, pp. 725–731, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. A. O'Garra, P. L. Vieira, P. Vieira, and A. E. Goldfeld, “IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage,” The Journal of Clinical Investigation, vol. 114, no. 10, pp. 1372–1378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. J. H.-M. Chang and D. Wakefield, “Uveitis: a global perspective,” Ocular Immunology & Inflammation, vol. 10, no. 4, pp. 263–279, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Wakefield and J. H. M. Chang, “Epidemiology of uveitis,” International Ophthalmology Clinics, vol. 45, no. 2, pp. 1–13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. J. T. Rosenbaum, H. O. McDevitt, R. B. Guss, and P. R. Egbert, “Endotoxin-induced uveitis in rats as a model for human disease,” Nature, vol. 286, no. 5773, pp. 611–613, 1980. View at Publisher · View at Google Scholar · View at Scopus
  99. J. H. Chang, P. J. McCluskey, and D. Wakefield, “Acute anterior uveitis and HLA-B27,” Survey of Ophthalmology, vol. 50, no. 4, pp. 364–388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. J. R. Smith, P. H. Hart, and K. A. Williams, “Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis,” Immunology and Cell Biology, vol. 76, no. 6, pp. 497–512, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Mérida, M. Sancho-Tello, M. Muriach, M. Miranda, A. Navea, and F. Bosch-Morell, “Lipoic acid lessens Th1-mediated inflammation in lipopolysaccharide-induced uveitis reducing selectively Th1 lymphocytes-related cytokines release,” Free Radical Research, vol. 47, no. 8, pp. 593–601, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. P. G. McMenamin and J. Crewe, “Endotoxin-induced uveitis: kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body,” Investigative Ophthalmology & Visual Science, vol. 36, no. 10, pp. 1949–1959, 1995. View at Google Scholar · View at Scopus
  103. J. M. Ruiz-Moreno, B. Thillaye, and Y. De Kozak, “Retino-choroidal changes in endotoxin-induced uveitis in the rat,” Ophthalmic Research, vol. 24, no. 3, pp. 162–168, 1992. View at Publisher · View at Google Scholar · View at Scopus
  104. P. Yang, A. F. De Vos, and A. Kijlstra, “Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide,” Investigative Ophthalmology & Visual Science, vol. 37, no. 1, pp. 77–85, 1996. View at Google Scholar · View at Scopus
  105. X.-Q. Liu, H. Kobayashi, Z.-B. Jin, A. Wada, and N. Nao-I, “Differential expression of Kir4.1 and aquaporin 4 in the retina from endotoxin-induced uveitis rat,” Molecular Vision, vol. 13, pp. 309–317, 2007. View at Google Scholar · View at Scopus
  106. P. Yang, A. F. de Vos, and A. Kijlstra, “Macrophages and MHC class II positive cells in the choroid during endotoxin induced uveitis,” British Journal of Ophthalmology, vol. 81, no. 5, pp. 396–401, 1997. View at Publisher · View at Google Scholar · View at Scopus
  107. J. H. Chang, P. McCluskey, and D. Wakefield, “Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea,” Investigative Ophthalmology & Visual Science, vol. 45, no. 6, pp. 1871–1878, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  109. S. K. Biswas, P. Bist, M. K. Dhillon et al., “Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance,” The Journal of Immunology, vol. 179, no. 6, pp. 4083–4092, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Kezic, S. Taylor, S. Gupta, S. R. Planck, H. L. Rosenzweig, and J. T. Rosenbaum, “Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF,” Journal of Leukocyte Biology, vol. 90, no. 2, pp. 305–311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. X. Wittebole, D. Castanares-Zapatero, and P. F. Laterre, “Toll-like receptor 4 modulation as a strategy to treat sepsis,” Mediators of Inflammation, vol. 2010, Article ID 568396, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. W. Chen, X. Hu, L. Zhao, S. Li, and H. Lu, “Expression of toll-like receptor 4 in uvea-resident tissue macrophages during endotoxin-induced uveitis,” Molecular Vision, vol. 15, pp. 619–628, 2009. View at Google Scholar · View at Scopus
  113. J. Wang, H. Lu, X. Hu et al., “Nuclear factor translocation and acute anterior uveitis,” Molecular Vision, vol. 17, pp. 170–176, 2011. View at Google Scholar · View at Scopus
  114. S. Yang, H. Lu, J. Wang, X. Qi, X. Liu, and X. Zhang, “The effect of toll-like receptor 4 on macrophage cytokines during endotoxin induced uveitis,” International Journal of Molecular Sciences, vol. 13, no. 6, pp. 7508–7520, 2012. View at Publisher · View at Google Scholar
  115. W. Shen, Y. Gao, B. Lu, Q. Zhang, Y. Hu, and Y. Chen, “Negatively regulating TLR4/NF-κB signaling via PPARα in endotoxin-induced uveitis,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 7, pp. 1109–1120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  116. F. Ekici, E. E. Karaca, Ş. Korkmaz et al., “Effect of the toll-like receptor 4 antagonist eritoran on retinochoroidal inflammatory damage in a rat model of endotoxin-induced inflammation,” Mediators of Inflammation, vol. 2014, Article ID 643525, 9 pages, 2014. View at Publisher · View at Google Scholar
  117. S. Rossi, C. Di Filippo, C. Gesualdo et al., “Protection from endotoxic uveitis by intravitreal resolvin D1: involvement of lymphocytes, mirnas, ubiquitin-proteasome, and M1/M2 macrophages,” Mediators of Inflammation, vol. 2015, Article ID 149381, 12 pages, 2015. View at Publisher · View at Google Scholar
  118. S. Mérida, M. Sancho-Tello, A. Navea, I. Almansa, M. Muriach, and F. Bosch-Morell, “An anti-interleukin-2 receptor drug attenuates T-helper 1 lymphocytes-mediated inflammation in an acute model of endotoxin-induced uveitis,” PLoS ONE, vol. 9, no. 3, Article ID e90216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. M. D. Liang, A. Bagchi, H. S. Warren et al., “Bacterial peptidoglycan-associated lipoprotein: a naturally occurring toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide,” Journal of Infectious Diseases, vol. 191, no. 6, pp. 939–948, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. F. P. da Silva, M. Aloulou, D. Skurnik et al., “CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation,” Nature Medicine, vol. 13, no. 11, pp. 1368–1374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Benoit, B. Desnues, and J.-L. Mege, “Macrophage polarization in bacterial infections,” The Journal of Immunology, vol. 181, no. 6, pp. 3733–3739, 2008. View at Publisher · View at Google Scholar · View at Scopus